Aqtion platform offers investors a gateway to investment opportunities in pre-vetted early-stage startups and also a secondary investment.
Ref 18
Sector:
Cybersecurity Blockchain Internet Hardware
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
$ 10,000,000
Series A
U.S.
2015
B2B2C
Developed technology
4.7
VCs, Private Investor
Convergence of trusted Computing's investment in endpoint security with the explosive opportunity in blockchain's anonymous transactions.
Cledo
Sector:
Healthcare AI
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 1,000,000
Seed
France
2018
B2B
4M€ in sales in 4Q2019
4.5
VCs, Private Investor
The only user friendly AI based medical imaging platform. Cledo is offering a ready to use solution to help Practitioners create AI tools applied to imaging.
Patho
Sector:
Healthcare AI
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 1,500,000
Seed
Italy
2012
B2B
Services
3.8
VCs, Private Investor
Integration the pathology detection based on AI, image recognition models to existing projects. BEP in revenue is in 2019. Target turnover in 2022- 10 M€
GetB
Sector:
Digital health
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
$ 3,000,000
Series A
Israel
2017
B2B, B2C, B2B2C
Beta
4.0
VCs, Private Investor
Dealing with lost of cognitive power by elderly people. Category: VR, medical devices, digital healthcare
Aevolve
Sector:
Blockchain +biotech
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 100,000,000
Seed
Switzerland
2018
B2C, B2B2C
MVP, asset connected
4.5
Institutional investor
Disruptive platform for future medical treatment
Medo
Sector:
Digital health + Blockchain
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 1,000,000
Seed
France
2019
B2B2C
4.3
VCs, Private Investor
Blockchain empowered platform for precision of medical diagnosis
Alab
Sector:
Medtech
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 30,000,000
Series C
the U.S.
2011
B2C
FDA approved
5.0
Private Investor
The FDA approved treatment that can be used for diseases for Alzheimer’s and diabetics .
Ely
Sector:
Digital Health
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 1,500,000
Seed
France
2018
B2B2C, B2B
Beta
4.0
VCs, Private Investor
Digital Platform for to evaluate the risk associated with major common pathologies. Categories: e-Health, Woman Health, Healthcare.
Dev_drug
Sector:
Biotech
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 30,000,000
IP
France
2014
Developed drug
Developed
4.8
VCs to Pharma
Patented technology of one of the major important mineral supplements. Clinically proven. Superior technology in terms of dosage, bioavailability, absorption, cost, efficiency.
DLife
Sector:
Healthcare + hospital
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 3,000,000
Seed
Switzerland
2019
B2C, B2B2C
Buz plan, partnerships
3.8
VCs, Private Investor
Predictive medicine: cells , DNA
BioxVSR
Sector:
Biotech
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 1,000,000
Seed
Italy
2010
B2B
Pre-clinical package
4.2
VCs, Private Investor
Senolytics: selectively kill senescent cells
GM
Sector:
Digital health
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 7,000,000
Series A
Israel
2016
B2B
Critical mass users, POC
4.0
VCs, Private Investor
Global Online Physicians Community Connecting the industry to physicians and connecting physicians to physicians (TRUSTED P2P)
Bcel
Sector:
Healthcare
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 4,000,000
Series A
France
2015
B2B
Revenue generated
4.8
VCs, Private Investor
Proprietary Technology. Quantitative Analysis for pre-clinical models. Permit conduct comparative studies between different labs. Currently specialized on 2 diseases.Categories: AI,ML, Healthcare.
Cel
Sector:
Biotech
Raising amount
Stage
Location
Founded
Bus.model
Product stage
Rating
Investor
€ 1,500,000
Series C
UK
2009
B2B
Stage 3 clinical trials
4.2
Private Investor
Cellular medicines, Stage 3 clinical trials